ShockWave Medical Statistics
Total Valuation
DLB has a market cap or net worth of $6.94 billion. The enterprise value is $6.28 billion.
| Market Cap | 6.94B |
| Enterprise Value | 6.28B |
Important Dates
The last earnings date was Thursday, July 31, 2025, after market close.
| Earnings Date | Jul 31, 2025 |
| Ex-Dividend Date | Aug 12, 2025 |
Share Statistics
DLB has 95.84 million shares outstanding. The number of shares has decreased by -0.19% in one year.
| Current Share Class | 61.18M |
| Shares Outstanding | 95.84M |
| Shares Change (YoY) | -0.19% |
| Shares Change (QoQ) | -0.59% |
| Owned by Insiders (%) | 0.58% |
| Owned by Institutions (%) | 61.01% |
| Float | 60.46M |
Valuation Ratios
The trailing PE ratio is 26.71 and the forward PE ratio is 17.96.
| PE Ratio | 26.71 |
| Forward PE | 17.96 |
| PS Ratio | 5.15 |
| Forward PS | 4.95 |
| PB Ratio | 2.66 |
| P/TBV Ratio | 4.16 |
| P/FCF Ratio | 15.84 |
| P/OCF Ratio | 14.90 |
| PEG Ratio | n/a |
Enterprise Valuation
The stock's EV/EBITDA ratio is 16.68, with an EV/FCF ratio of 14.33.
| EV / Earnings | 23.75 |
| EV / Sales | 4.66 |
| EV / EBITDA | 16.68 |
| EV / EBIT | 21.70 |
| EV / FCF | 14.33 |
Financial Position
The company has a current ratio of 3.44, with a Debt / Equity ratio of 0.01.
| Current Ratio | 3.44 |
| Quick Ratio | 3.09 |
| Debt / Equity | 0.01 |
| Debt / EBITDA | 0.10 |
| Debt / FCF | 0.09 |
| Interest Coverage | n/a |
Financial Efficiency
Return on equity (ROE) is 10.50% and return on invested capital (ROIC) is 7.02%.
| Return on Equity (ROE) | 10.50% |
| Return on Assets (ROA) | 5.86% |
| Return on Invested Capital (ROIC) | 7.02% |
| Return on Capital Employed (ROCE) | 10.30% |
| Revenue Per Employee | $647,554 |
| Profits Per Employee | $127,046 |
| Employee Count | 2,080 |
| Asset Turnover | 0.44 |
| Inventory Turnover | 4.61 |
Taxes
In the past 12 months, DLB has paid $55.85 million in taxes.
| Income Tax | 55.85M |
| Effective Tax Rate | 17.37% |
Stock Price Statistics
The stock price has decreased by -5.06% in the last 52 weeks. The beta is 0.90, so DLB's price volatility has been similar to the market average.
| Beta (5Y) | 0.90 |
| 52-Week Price Change | -5.06% |
| 50-Day Moving Average | 74.91 |
| 200-Day Moving Average | 77.35 |
| Relative Strength Index (RSI) | 39.42 |
| Average Volume (20 Days) | 347,722 |
Short Selling Information
The latest short interest is 1.45 million, so 1.51% of the outstanding shares have been sold short.
| Short Interest | 1.45M |
| Short Previous Month | 1.23M |
| Short % of Shares Out | 1.51% |
| Short % of Float | 2.39% |
| Short Ratio (days to cover) | 3.72 |
Income Statement
In the last 12 months, DLB had revenue of $1.35 billion and earned $264.26 million in profits. Earnings per share was $2.71.
| Revenue | 1.35B |
| Gross Profit | 1.19B |
| Operating Income | 289.23M |
| Pretax Income | 258.86M |
| Net Income | 264.26M |
| EBITDA | 376.41M |
| EBIT | 289.23M |
| Earnings Per Share (EPS) | $2.71 |
Balance Sheet
The company has $699.33 million in cash and $39.11 million in debt, giving a net cash position of $660.22 million or $6.89 per share.
| Cash & Cash Equivalents | 699.33M |
| Total Debt | 39.11M |
| Net Cash | 660.22M |
| Net Cash Per Share | $6.89 |
| Equity (Book Value) | 2.61B |
| Book Value Per Share | 27.19 |
| Working Capital | 949.33M |
Cash Flow
In the last 12 months, operating cash flow was $465.54 million and capital expenditures -$27.48 million, giving a free cash flow of $438.05 million.
| Operating Cash Flow | 465.54M |
| Capital Expenditures | -27.48M |
| Free Cash Flow | 438.05M |
| FCF Per Share | $4.57 |
Margins
Gross margin is 88.52%, with operating and profit margins of 21.47% and 19.62%.
| Gross Margin | 88.52% |
| Operating Margin | 21.47% |
| Pretax Margin | 23.87% |
| Profit Margin | 19.62% |
| EBITDA Margin | 27.95% |
| EBIT Margin | 21.47% |
| FCF Margin | 32.52% |
Dividends & Yields
This stock pays an annual dividend of $1.32, which amounts to a dividend yield of 1.82%.
| Dividend Per Share | $1.32 |
| Dividend Yield | 1.82% |
| Dividend Growth (YoY) | 10.00% |
| Years of Dividend Growth | 10 |
| Payout Ratio | 48.71% |
| Buyback Yield | 0.19% |
| Shareholder Yield | 2.01% |
| Earnings Yield | 3.81% |
| FCF Yield | 6.31% |
Analyst Forecast
The average price target for DLB is $101.75, which is 40.58% higher than the current price. The consensus rating is "Strong Buy".
| Price Target | $101.75 |
| Price Target Difference | 40.58% |
| Analyst Consensus | Strong Buy |
| Analyst Count | 4 |
| Revenue Growth Forecast (5Y) | n/a |
| EPS Growth Forecast (5Y) | n/a |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | |
| Lynch Upside | |
| Graham Number | |
| Graham Upside |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
DLB has an Altman Z-Score of 9.8 and a Piotroski F-Score of 5.
| Altman Z-Score | 9.8 |
| Piotroski F-Score | 5 |